Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Dermata Therapeutics Inc (NQ: DRMA )

1.385 UNCHANGED
Streaming Delayed Price Updated: 3:56 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dermata Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024
Via ACCESSWIRE
Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Via ACCESSWIRE
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Via ACCESSWIRE
Peering Into Dermata Therapeutics's Recent Short Interest
Via Benzinga
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Via ACCESSWIRE
Why Is Dermata Therapeutics (DRMA) Stock Up 200% Today?
Dermata Therapeutics stock is up on Wednesday with heavy trading of the company's shares despite a lack of news this morning. 
Via InvestorPlace
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
Via Benzinga
Topics Stocks
Exposures US Equities
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
Via ACCESSWIRE
Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
Via ACCESSWIRE
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
7 F-Rated Growth Stocks to Avoid Like the Plague in August 2024
If your growth stocks have stopped growing then you may be holding on to F-rated growth stocks. It's time to sell. 
Via InvestorPlace
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
Dermata Therapeutics Shares Are Trading Over 100%: What You Need To Know
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares are trading higher Wednesday. Here's what you need to know. 
Via Benzinga
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings
Via Benzinga
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Is Azitra (AZTR) Stock Down 75% Today?
Azitra stock is falling on Wednesday as shares of AZTR come off of a massive rally yesterday alongside a new patent update. 
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
Why Is Nuzee (NUZE) Stock Up 133% Today?
Nuzee stock is up on Wednesday with heavy trading of NUZE shares despite a lack of news from the coffee machine company. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with! 
Via InvestorPlace
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
Via ACCESSWIRE
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q1 2024
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.